Novartis to acquire Japanese giant Takeda's eye drug assets for $3.4b

Novartis AG agreed to pay $3.4 billion for eye-disease medicines that Takeda Pharmaceutical Co. is selling to shed debt after its $62 billion acquisition of Shire Plc.